<VariationArchive VariationID="53933" VariationName="NM_000492.4(CFTR):c.4251del (p.Glu1418fs)" VariationType="Deletion" Accession="VCV000053933" Version="24" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-05-19" DateCreated="2018-01-06" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="68600" VariationID="53933">
      <GeneList>
        <Gene Symbol="CFTR" FullName="CF transmembrane conductance regulator" GeneID="1080" HGNC_ID="HGNC:1884" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117480025" stop="117668665" display_start="117480025" display_stop="117668665" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117120016" stop="117308718" display_start="117120016" display_stop="117308718" Strand="+" />
          </Location>
          <OMIM>602421</OMIM>
        </Gene>
        <Gene Symbol="LOC111674477" FullName="CFTR intron 23 enhancer" GeneID="111674477" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117665695" stop="117667138" display_start="117665695" display_stop="117667138" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000492.4(CFTR):c.4251del (p.Glu1418fs)</Name>
      <CanonicalSPDI>NC_000007.14:117666914:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117666915" stop="117666915" display_start="117666915" display_stop="117666915" variantLength="1" positionVCF="117666914" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117306969" stop="117306969" display_start="117306969" display_stop="117306969" variantLength="1" positionVCF="117306968" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>4382delA</Name>
      </OtherNameList>
      <ProteinChange>E1418fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.117306970del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.117306970del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.117666916del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.117666916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.206133del">
            <Expression>NG_016465.4:g.206133del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_056133.2" sequenceAccession="NG_056133" sequenceVersion="2" change="g.1322del">
            <Expression>NG_056133.2:g.1322del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.4251del" MANESelect="true">
            <Expression>NM_000492.4:c.4251del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000483.3" sequenceAccession="NP_000483" sequenceVersion="3" change="p.Glu1418fs">
            <Expression>NP_000483.3:p.Glu1418fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_663" sequenceAccession="LRG_663">
            <Expression>LRG_663:g.206133del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.4251delA">
            <Expression>NM_000492.3:c.4251delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA328122" DB="ClinGen" />
        <XRef Type="rs" ID="397508706" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND Cystic fibrosis" Accession="RCV000056391" Version="10">
        <ClassifiedConditionList TraitSetID="1961">
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2017-03-17" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND not provided" Accession="RCV000727667" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-12" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND not specified" Accession="RCV001002184" Version="8">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND CFTR-related disorder" Accession="RCV001826685" Version="1">
        <ClassifiedConditionList TraitSetID="52839">
          <ClassifiedCondition>CFTR-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-03-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND Bronchiectasis with or without elevated sweat chloride 1" Accession="RCV003474602" Version="1">
        <ClassifiedConditionList TraitSetID="2434">
          <ClassifiedCondition DB="MedGen" ID="C2749757">Bronchiectasis with or without elevated sweat chloride 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.4251del (p.Glu1418fs) AND Hereditary pancreatitis" Accession="RCV002247438" Version="1">
        <ClassifiedConditionList TraitSetID="3226">
          <ClassifiedCondition DB="MedGen" ID="C0238339">Hereditary pancreatitis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-03-17" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2018-01-06" MostRecentSubmission="2024-02-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15638824</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23974870</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25583415</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28546993</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30444886</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7689013</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7691344</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://cftr2.org</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="1961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3226" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3261" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary pancreatitis</ElementValue>
                <XRef ID="Hereditary+pancreatitis/3373" DB="Genetic Alliance" />
                <XRef ID="68072000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary chronic pancreatitis</ElementValue>
                <XRef ID="MONDO:0008185" DB="MONDO" />
                <XRef ID="676" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HP</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HPC</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PCTT</ElementValue>
                <XRef Type="MIM" ID="167800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPANC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SPINK1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PRSS1-Related Hereditary Pancreatitis</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CTRC-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CFTR-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PRSS1-related hereditary pancreatitis (HP) is characterized by episodes of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP: &gt;1 episode of AP), with frequent progression to chronic pancreatitis (CP). Manifestations of acute pancreatitis can range from vague abdominal pain lasting one to three days to severe abdominal pain lasting days to weeks and requiring hospitalization.</Attribute>
                <XRef ID="NBK84399" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PCTT: PRSS1-Related Hereditary Pancreatitis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6632" />
                <XRef ID="6632" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22379635</ID>
                <ID Source="BookShelf">NBK84399</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24624459</ID>
                <ID Source="BookShelf">NBK190101</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng104</URL>
                <CitationText>UK NICE Guideline NG104, Pancreatitis, 2020</CitationText>
              </Citation>
              <XRef ID="676" DB="Orphanet" />
              <XRef ID="C0238339" DB="MedGen" />
              <XRef ID="MONDO:0008185" DB="MONDO" />
              <XRef Type="MIM" ID="167800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52839" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42248" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CFTR-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CFTR-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CFTR-related condition</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CFTR-RD</ElementValue>
              </Symbol>
            </Trait>
          </TraitSet>
          <TraitSet ID="2434" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1065" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bronchiectasis with or without elevated sweat chloride 1</ElementValue>
                <XRef ID="MONDO:0008887" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystic Fibrosis-Like Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BESC1</ElementValue>
                <XRef Type="MIM" ID="211400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18054" />
                <XRef ID="18054" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="60033" DB="Orphanet" />
              <XRef ID="C2749757" DB="MedGen" />
              <XRef ID="MONDO:0008887" DB="MONDO" />
              <XRef Type="MIM" ID="211400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="146935" SubmissionDate="2017-06-29" DateLastUpdated="2018-01-06" DateCreated="2013-10-18">
        <ClinVarSubmissionID localKey="4382delA|Cystic fibrosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000071486" DateUpdated="2018-01-06" DateCreated="2013-10-18" Type="SCV" Version="4" SubmitterName="CFTR2" OrgID="500092" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://cftr2.org</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sosnay PR et al. (Nat Genet 2013)</Attribute>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Glu1418ArgfsX14</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.4251delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>https://cftr2.org</URL>
        </Citation>
        <StudyName>CFTR2</StudyName>
        <StudyDescription>Clinical and Functional TRanslation of CFTR</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB2827387</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2307368" SubmissionDate="2019-09-16" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="c.4251delA|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001169387" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="CFTR-France" OrgID="507119" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Claustres M et al. (Hum Mutat 2017)</Attribute>
          <Citation>
            <ID Source="PubMed">28603918</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.4251delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">cystic fibrosis</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28603918</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB6300041</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7609560" SubmissionDate="2023-10-05" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="a863846|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004085785" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7691344</ID>
          </Citation>
          <Comment>The c.4251delA pathogenic mutation (also known as 4382delA), located in coding exon 27 of the CFTR gene, results from a deletion of one nucleotide at nucleotide position 4251, causing a translational frameshift with a predicted alternate stop codon (p.E1418Rfs*14). This alteration occurs at the 3' terminus of the CFTR gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 63 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This mutation has been reported in multiple individuals with cystic fibrosis and elevated sweat chloride levels (Claustres M et al. Hum. Mol. Genet., 1993 Aug;2:1209-13; Sosnay PR et al. Nat. Genet., 2013 Oct;45:1160-7. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry General Variant Classification Scheme_2022</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/5hsvndk6/ambry_general_variant_classification_scheme_2022.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.4251delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough091523</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865829" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000492.4:c.4251del|OMIM:211400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004213293" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.4251del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7910754" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="5c1fd760867feca1f64a9c65fee7279387519e0e39dbb1872a9466271f6864e8|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004234594" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.4251del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="123062" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2013-07-03">
        <ClinVarSubmissionID localKey="703101|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000075132" DateUpdated="2024-02-20" DateCreated="2013-07-03" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7691344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15638824</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 53933). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This premature translational stop signal has been observed in individual(s) with classic symptoms of Cystic Fibrosis (PMID: 7691344, 15638824, 23974870; www.CFTR2.org). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu1418Argfs*14) in the CFTR gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 63 amino acid(s) of the CFTR protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117306969del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2013March</SubmissionName>
          <SubmissionName>2017March_Invitae</SubmissionName>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1363371" SubmissionDate="2018-01-25" DateLastUpdated="2018-01-06" DateCreated="2018-01-06">
        <ClinVarSubmissionID localKey="NM_000492.3:c.4251delA|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697019" DateUpdated="2018-01-06" DateCreated="2018-01-06" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7689013</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7691344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25583415</ID>
          </Citation>
          <Comment>Variant summary: The CFTR c.4251delA (p.Glu1418Argfs) variant results in a premature termination codon, predicted to cause a truncated or absent CFTR protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.4364C&gt;G, p.Ser1455X; c.4426C&gt;T, p.Gln1476X). One in silico tool predicts a damaging outcome for this variant. The variant of interest has not been found in a large, broad control population, ExAC in 120796 control chromosomes. This variant was found in multiple CF patients with mean sweat chloride conc 60mM (Sosnay_Nature Genetics_2013) including in a patient in compound heterozigosity with c.3849+1G&gt;A (not in our internal database) with a presentation characteristic of Pseudo-Bartters syndrome, a rare typical presentation of CF (Nahida_ActaPed_2011). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic, including CFTR2 where it was reported in 62 patients, with an average of 103 mEq/L sweat chloride, (33% with PI, 40% with Pseudomonas infection). Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="397508706" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.4251delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1668381" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="28067_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000854976" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="-" referenceAllele="A" start="117306970" stop="117306970" variantLength="1" />
            <GeneLocation>NM_000492.3:Ex27</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD930931" />
            <XRef DB="dbSNP" ID="397508706" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2284635" SubmissionDate="2019-08-05" DateLastUpdated="2020-02-10" DateCreated="2020-02-10">
        <ClinVarSubmissionID localKey="2202634|MedGen:CN169374" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001160055" DateUpdated="2020-02-10" DateCreated="2020-02-10" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CFTR c.4251delA; p.Glu1418fs variant (rs397508706), also known as 4382delA, is reported in the literature in multiple individuals affected with cystic fibrosis, including in a compound heterozygous state with a known pathogenic CFTR allele (Castaldo 2005, Claustres 1993, Nahida 2011, Sermet-Gaudelus 2010, Sosnay 2013). This variant is reported as pathogenic by multiple laboratories in ClinVar (Variation ID: 53933), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant results in a premature termination codon in the last exon of the CFTR gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein that would include a sequence of 14 amino acid residues not usually present. Based on available information, the p.Glu1418fs variant is considered to be pathogenic. References: Castaldo G et al. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet. 2005 Jan;69(Pt 1):15-24. Claustres M et al. Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France. Hum Mol Genet. 1993 Aug;2(8):1209-13. Nahida el-R et al. Pseudo-Bartter's syndrome revealing cystic fibrosis in an infant caused by 3849 + 1G&gt;A and 4382delA compound heterozygosity. Acta Paediatr. 2011 Nov;100(11):e234-5. Sermet-Gaudelus I et al. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Thorax. 2010 Jun;65(6):539-44. Sosnay PR Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013 Oct;45(10):1160-7.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117306970delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Aug 2019 ARUP</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3375281" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_000492.3:c.4251delA|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001714848" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28546993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30444886</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Comment>PVS1_strong, PM2, PS3, PM3, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000492.3:exon 27</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.4251delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4070255" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000492.4:c.4251del|CFTR-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002075959" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.4251del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CFTR-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932674" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000007.14:g.117666915_117666915delA|OMIM:167800" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518692" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.117666915_117666915delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="167800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7910754" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4932674" TraitType="Disease" MappingType="XRef" MappingValue="167800" MappingRef="OMIM">
        <MedGen CUI="C0238339" Name="Hereditary pancreatitis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="146935" TraitType="Disease" MappingType="Name" MappingValue="Cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363371" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7609560" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4070255" TraitType="Disease" MappingType="Name" MappingValue="CFTR-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="CFTR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865829" TraitType="Disease" MappingType="XRef" MappingValue="211400" MappingRef="OMIM">
        <MedGen CUI="C2749757" Name="Bronchiectasis with or without elevated sweat chloride 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1668381" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3375281" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2284635" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="123062" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307368" TraitType="Disease" MappingType="Name" MappingValue="cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

